Lack of Association Between Rs2067474 Polymorphism in the Histamine Receptor H2 Gene and Gastric Cancer In Latvian Population

Open access

Abstract

Histamine has an important role in the process of the gastric mucosa inflammation acting via histamine receptor H2 (encoded by the gene HRH2). Single nucleotide polymorphism of the enhancer element of HRH2 gene promoter rs2067474 (1018G>A)may be associated with changes of expression of the receptor. We attempted to clarify the association of this polymorphism with gastric cancer and/or atrophic gastritis in the Latvian (Caucasian) population. The study group consisted of 121 gastric cancer patients and 650 patients with no evidence of gastric neoplasia on upper gastrointestinal endoscopy. Genotyping for rs2067474 was performed with the TaqMan probe-based system using a commercially available probe for RT-PCR. The frequency of the A allele in the gastric cancer group was 0.41% and in the control group — 1.54% (p = 0.231). No significant differences were found comparing genotypes between gastric cancer versus control patients (OR = 0.236, CI95% = 0.030–1.896), patients with (n = 165) versus without (n = 485) gastric metaplastic lesions (OR = 0.854, CI95% = 0.288–2.540) and patients with (n = 297) and without (n = 353) gastric atrophic lesions (OR = 1.145, CI95% = 0.451–2.906). Our findings suggest that the HRH2 -1018G>A polymorphism (rs2067474) is neither associated with gastric cancer nor the grade of atrophic gastritis in the Latvian (Caucasian) population.

Alzahrani, S., Lina, T. T., Gonzalez, J., Pinchuk, I. V., Beswick, E. J., Reyes, V. (2014). Effect of Helicobacter pylori on gastric epithelial cells. World J. Gastroenterol., 20 (36), 12767–12780.

Anonymous (1994). Schistosomes, liver flukes and Helicobacter pylori. World Health Organisation, International Agency for Research on Cancer (IARC) Working Group on the evaluation of carcinogenic risks to human. IARC Monogr. Eval. Carcinog. Risks Hum., 61, 269.

Arisawa, T., Tahara, T., Ozaki, K., Matsue, Y., Minato, T., Yamada, H., Nomura, T., Hayashi, R., Matsunaga, K., Fukumura, A., Nakamura, M., Toshkuni, N., Shiroeda, H., Shibata, T. (2012). Association between common genetic variant of HRH2 and gastric cancer risk. Int. J. Oncol., 41 (2), 487–503.

Auton, A., Brooks, L. D., Durbin, R. M., Garrison, E. P., Kang, H. M., Korbel, J. O., Marchini, J. L., McCarthy, S., McVean, G. A., Abecasis, G. R., 1000 Genomes Project Consortium (2015). A global reference for human genetic variation. Nature, 526 (7571), 68–74.

Bosman, F. T., Carneiro, F., Hruban, R. H., Theise, N. D. (eds.) (2010). IARC WHO Classification of Tumours of the Digestive System, fourth edition. World Health Organization, Lyon. 418 pp.

Cai, W. K., Zhang, J. B., Wang, N. M., Wang, Y. L., Lu, J., He, G. H. (2015). Lack of association between rs2067474 polymorphism in histamine receptor H2 gene and breast cancer in Chinese Han population. Sci. World J., 2015, 545292.

Ched, D., Aihara, T., Zhao, C. M., Hakanson, R., Okabe, S. (2006). Differentiation of the gastric mucosa. I. Role of histamine in control of function and integrity of oxyntic mucosa: Understanding gastric physiology through disruption of targeted genes. Amer. J. Physiol. Gastrointest. Liver Physiol., 291 (4), G539–G544.

Dixon, M. F., Genta, R. M., Yardley, J. H., Correa, P. (1996). Classification and grading of gastritis. The updated Sydney System. International workshop on the histopathology of gastritis, Houston 1994. Amer. J. Surg. Pathol., 20 (10), 1161–1181.

de Esch, I. J., Thurmond, R. L., Jongejan, A., Leurs, R. (2005). The histamine H4 receptor as a new therapeutic target for inflammation. Trends in Pharmacol. Sci., 26 (9), 462–469.

Edge, S. B., Byrd, D. R., Compton, C. C., Fritz, A. G., Greene, F. L., Trotti, A. (eds.) (2009). AJCC Cancer Staging Manual. 7th edn. Springer-Verlag, New York. 648 pp.

Ermani, S., Gespach, C., Forgue-Lafitte, M. E., Broer, Y., Rosselin, G. (1983). Histamine and VIP interactions with receptor-cyclic AMP systems in the human gastric cancer cell line HGT-1. Life Sci., 33 (5), 415–423.

Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., Bray, F. (eds.) (2013). GLOBOCAN 2012: Estimated Cancer Incidence and Mortality Worldwide in 2012. IARC CancerBase No. 11. International Agency for Research on Cancer, Lyon. Available from http://globocan.iarc.fr (accessed 03.11.2017).

Garcia-Martin, E., Ayuso, P., Luengo, A., Martinez, C., Agudez, J. A. (2008). Genetic variability of histamine receptors in patients with Parkinson’s disease. BioMed Central Med. Gen., 9, 15.

Gricco, G. P., Mohamad, N. A., Sambuco, L. A., Genre, F., Croci, M., Gutierrez, A. S., Medina, V. A., Bergoc, R. M., Rivera, E. S., Martin, G. A. (2008). Histamine regulates pancreatic carcinoma cell growth through H3 and H4 receptors. Inflamm. Res., 57 (Suppl 1), S23–S24.

Guo, Y., Jamison, D. C. (2005). The distribution of SNPs on human gene regulatory regions. BioMed Central Genom., 6, 140.

Hakanson, R., Bottcher, G., Ekblad, E., Panula, P., Simonsson, M., Dohlsten, M., Hallberg, T., Sundler, F. (1986). Histamine in endocrine cells in the stomach. A survey of several species using a panel of histamine. Histo-chemistry, 86 (1), 5–17.

Hill, S. J., Ganellin, C. R., Timmerman, H., Schwartz, J. C., Shankley, N. P., Young, J. M., Schunack, W., Levi, R., Hass, H. L. (1997). International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmac. Rev., 49 (3), 253–278.

Kong, W. Q., Bai, R., Liu, T., Cai, C. L., Liu, M., Li, X., Tang, H. (2012). MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma. FEBS J., 279 (7), 1252–1260.

Lampiasi, N., Azzolina, A., Montalto, G., Cervello, M. (2007). Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells. Exper. Mol. Med., 39 (3), 284–294.

Lauren, P. (1965). The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol. Et Microbiol. Scand., 64, 31–49.

Mancama, D., Arranz, M. J., Munro, J., Osborne, S., Makoff, A., Collier, D., Kerwin, R. (2002). Investigation of promoter variants of the histamine 1 and 2 receptors in schizophrenia and clozapine response. Neurosci. Lett., 333 (3), 207–211.

McGowan, C. C., Cover, T. L., Blaster, M. J. (1996). Helicobacter pylori and gastric acid: Biological and therapeutic implications. Gastroenterology, 110 (3), 926–938.

Nomura, T., Tahara, T., Shiroeda, H., Minato, T., Matsue, Y., Hayashi, R., Matsunaga, K., Otsuka, T., Nakamura, M., Toshikuni, N., Shibata, T., Arisawa, T. (2013). Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium. BioMed Central Gastroenterol., 13,1.

Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N., Sibley, R. K. (1991). Helicobacter pylori infection and the risk of gastric carcinoma. New Engl. J. Med., 325 (16), 1127–1131.

Rugge, M., Capelle, L. G., Cappellesso, R., Nitti, D., Kuipers, E. J. (2013). Precancerous lesions in the stomach: From biology to clinical patient management. Best Practice Res. Clin. Gastroenterol., 27, 205–223.

Wroblewski, L. E., Peek, R. M., Wilson, K. T. (2010). Helicobacter pylori and gastric cancer: Factors that modulate disease risk. Clin. Microbiol. Rev., 23 (4), 713–739.

Yamada, H., Tahara, T., Shiroeda, H., Hayashi, R., Saito, T., Nakamura, M., Tsuchishima, M., Tsutsumi, M., Shibata, T., Arisawa, T. (2012). Effects of –1018 G A polymorphism of HRH2 (rs2607474) on the severity of gastric mucosal atrophy. J. Gastrointest. Liver Dis., 21 (2), 139–143.

Journal Information

CiteScore 2017: 0.22

SCImago Journal Rank (SJR) 2017: 0.127
Source Normalized Impact per Paper (SNIP) 2017: 0.211

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 90 90 15
PDF Downloads 77 77 10